- Home
- ARVN vs GRVY Comparison
ARVN vs GRVY Comparison
Compare ARVN & GRVY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- GRVY
- Stock Information
- Founded
- ARVN 2015
- GRVY 2000
- Country
- ARVN United States
- GRVY South Korea
- Employees
- ARVN N/A
- GRVY N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- GRVY Business Services
- Sector
- ARVN Health Care
- GRVY Consumer Discretionary
- Exchange
- ARVN Nasdaq
- GRVY Nasdaq
- Market Cap
- ARVN 456.2M
- GRVY 442.6M
- IPO Year
- ARVN 2018
- GRVY 2005
- Fundamental
- Price
- ARVN $7.58
- GRVY $62.65
- Analyst Decision
- ARVN Buy
- GRVY
- Analyst Count
- ARVN 21
- GRVY 0
- Target Price
- ARVN $20.53
- GRVY N/A
- AVG Volume (30 Days)
- ARVN 1.8M
- GRVY 7.9K
- Earning Date
- ARVN 08-05-2025
- GRVY 08-12-2025
- Dividend Yield
- ARVN N/A
- GRVY N/A
- EPS Growth
- ARVN N/A
- GRVY N/A
- EPS
- ARVN N/A
- GRVY 7.83
- Revenue
- ARVN $426,900,000.00
- GRVY $339,753,162.00
- Revenue This Year
- ARVN $7.57
- GRVY N/A
- Revenue Next Year
- ARVN N/A
- GRVY N/A
- P/E Ratio
- ARVN N/A
- GRVY $8.11
- Revenue Growth
- ARVN 498.74
- GRVY N/A
- 52 Week Low
- ARVN $5.90
- GRVY $53.12
- 52 Week High
- ARVN $29.96
- GRVY $80.36
- Technical
- Relative Strength Index (RSI)
- ARVN 48.51
- GRVY 46.39
- Support Level
- ARVN $7.41
- GRVY $61.50
- Resistance Level
- ARVN $8.05
- GRVY $64.00
- Average True Range (ATR)
- ARVN 0.39
- GRVY 1.30
- MACD
- ARVN -0.03
- GRVY -0.06
- Stochastic Oscillator
- ARVN 31.33
- GRVY 37.10
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About GRVY GRAVITY Co. Ltd. American Depository Shares
GRAVITY Co Ltd is an online and mobile games developer and publisher based in Korea. Its principal product, Ragnarok Online, is an online game which is available in more than 91 markets. Its games include Ragnarok Online, Requiem, Dragonica (Dragon Saga), Ragnarok Online II, Requiem Online, and R.O.S.E. Online. The company generates revenue from online games, mobile games and other sources including character based merchandise and animation.